Correlation Between PhaseBio Pharmaceuticals and Ceapro
Can any of the company-specific risk be diversified away by investing in both PhaseBio Pharmaceuticals and Ceapro at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PhaseBio Pharmaceuticals and Ceapro into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PhaseBio Pharmaceuticals and Ceapro Inc, you can compare the effects of market volatilities on PhaseBio Pharmaceuticals and Ceapro and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PhaseBio Pharmaceuticals with a short position of Ceapro. Check out your portfolio center. Please also check ongoing floating volatility patterns of PhaseBio Pharmaceuticals and Ceapro.
Diversification Opportunities for PhaseBio Pharmaceuticals and Ceapro
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between PhaseBio and Ceapro is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding PhaseBio Pharmaceuticals and Ceapro Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ceapro Inc and PhaseBio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PhaseBio Pharmaceuticals are associated (or correlated) with Ceapro. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ceapro Inc has no effect on the direction of PhaseBio Pharmaceuticals i.e., PhaseBio Pharmaceuticals and Ceapro go up and down completely randomly.
Pair Corralation between PhaseBio Pharmaceuticals and Ceapro
Assuming the 90 days horizon PhaseBio Pharmaceuticals is expected to generate 3.17 times more return on investment than Ceapro. However, PhaseBio Pharmaceuticals is 3.17 times more volatile than Ceapro Inc. It trades about 0.18 of its potential returns per unit of risk. Ceapro Inc is currently generating about 0.05 per unit of risk. If you would invest 0.06 in PhaseBio Pharmaceuticals on August 31, 2024 and sell it today you would lose (0.03) from holding PhaseBio Pharmaceuticals or give up 50.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 10.65% |
| Values | Daily Returns |
PhaseBio Pharmaceuticals vs. Ceapro Inc
Performance |
| Timeline |
| PhaseBio Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Ceapro Inc |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
PhaseBio Pharmaceuticals and Ceapro Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PhaseBio Pharmaceuticals and Ceapro
The main advantage of trading using opposite PhaseBio Pharmaceuticals and Ceapro positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PhaseBio Pharmaceuticals position performs unexpectedly, Ceapro can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ceapro will offset losses from the drop in Ceapro's long position.The idea behind PhaseBio Pharmaceuticals and Ceapro Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Ceapro vs. Biotron Limited | Ceapro vs. biOasis Technologies | Ceapro vs. Covalon Technologies | Ceapro vs. Mosaic Immunoengineering |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |